...
首页> 外文期刊>BMC Oral Health >Effect of epinephrine on the absorption of lidocaine following application to the oral mucosa in rats
【24h】

Effect of epinephrine on the absorption of lidocaine following application to the oral mucosa in rats

机译:肾上腺素对大鼠口腔粘膜后利多卡因吸收的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We investigated the role of epinephrine in prolonging the localization of lidocaine on the oral mucosa and inhibiting its absorption in the blood of rats. We used 7–8-week-old pathogen-free Wistar male rats (n?=?128) for our study. We divided them into the control group administered with 14C-labeled lidocaine hydrochloride gel only and the study group administered with 14C-labeled lidocaine hydrochloride gel with epinephrine. The medications were administered in the palatal mucosa of the rats. The amount of mucosa, palatine bone, and serum lidocaine was measured by radioactivity using a liquid scintillation counter and was observed using autoradiograms. Initially, there was no significant difference in the lidocaine levels between the lidocaine and lidocaine with epinephrine groups in the palatal mucosa (751.9?±?133.8 vs. 669.8?±?101.6?ng/mg [2?min]). After 4?min, the values were significantly lower in the lidocaine with epinephrine group (1040.0?±?142.8 vs. 701.2?±?109.0?ng/mg [20?min]). After 40?min, the lidocaine level became significantly higher in the lidocaine with epinephrine group (586.8?±?112.4 vs. 1131.3?±?155.2?ng/mg [40?min]). Similar results were observed in the palatine bone and serum. Epinephrine prolonged the localization of lidocaine applied to the mucosa and inhibited its absorption into the bloodstream of rats. Clinical studies are required to evaluate the use of epinephrine-containing topical anesthetics on the oral mucosa.
机译:我们调查了肾上腺素在延长人粘膜上的Lid Caine局部化并抑制大鼠血液中的吸收的作用。我们使用7-8周的无病原体Wistar雄性大鼠(n?= 128)。我们将它们分成施用14℃标记的利多卡因盐酸凝胶的对照组,并用肾上腺素用14℃标记的利多卡因盐酸胶凝胶施用的研究组。在大鼠的腭粘膜中施用药物。通过使用液体闪烁计数器通过放射性测量粘膜,腭骨和血清利多卡因的量,并使用足够的放射仪观察。最初,利多卡因和利多卡因与腭粘膜中的肾上腺素组之间的利多卡因水平没有显着差异(751.9?±133.8 vs.669.8?±101.6?Ng / mg [2?min])。在4℃后,利多卡因的Lidocaine在肾上腺素组中显着降低(1040.0?±142.8〜701.2?±109.0?Ng / mg [20≤min])。在40℃之后,利多卡因利多卡因的利多卡因水平在肾上腺素组(586.8?±112.4〜1131.3〜±155.2〜Ng / mg [40≤min])中显着高。在腭骨和血清中观察到类似的结果。肾上腺素延长了施用于粘膜的利多卡因的定位,并抑制其吸收大鼠的血液。需要临床研究来评估含肾上腺素的局部麻醉剂对口腔粘膜的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号